KLRK1 and neoplasm: The presence of NKG2D‐expressing cytotoxic lymphocytes in the TME favors the selection of tumor cell clones releasing soluble NKG2D ligands from their surface through alternative splicing, proteolytic shedding, or exosome secretion [131].